
Thermo Fisher Scientific Inc: updates and filings
Price
$686.79
November 17, 2026Market cap $255B
What Ploutos Investor adds for Thermo Fisher Scientific
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 21, 2026next Jan 25, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
July 2026
May 2026
March 2026
February 2026
January 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 5, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Oct 30, 2026Officer or director changeForm8-K
- Oct 30, 2026Quarterly reportfor the period to Sep 26, 2026Form10-Q
- Oct 21, 2026Results of operationsForm8-K
- Jul 31, 2026Quarterly reportfor the period to Jun 27, 2026Form10-Q
- Jul 28, 2026Filing (amendment)Form144/A
- Jul 23, 2026Results of operationsForm8-K
- Jun 23, 2026Employee stock plan reportfor the period to Dec 31, 2025Form11-K
- May 28, 2026Conflict minerals reportFormSD
- May 26, 2026Shareholder voteForm8-K
- May 11, 2026Additional annual meeting materialFormDEFA14A
- May 1, 2026Quarterly reportfor the period to Mar 28, 2026Form10-Q
- Apr 30, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 23, 2026Results of operationsForm8-K
- Apr 7, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Apr 7, 2026Additional annual meeting materialFormDEFA14A
- Apr 7, 2026Annual meeting proxy statementFormDEF 14A
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 24, 2026Other material eventsForm8-K
- Feb 26, 2026Annual reportfor the period to Dec 31, 2025Form10-K
- Feb 12, 2026Material agreement entered, other material eventsForm8-K
- Jan 29, 2026Results of operationsForm8-K
- Jan 23, 2026One of its securities removed from an exchange (usually a matured note)Form25-NSE
- Jan 21, 2026One of its securities removed from an exchange (usually a matured note)Form25-NSE
- Jan 12, 2026Officer or director changeForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 5, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Oct 30, 2026 | 8-K | Officer or director change | Document |
| Oct 30, 2026 | 10-Q | Quarterly reportfor the period to Sep 26, 2026 | Document |
| Oct 21, 2026 | 8-K | Results of operations | Document |
| Jul 31, 2026 | 10-Q | Quarterly reportfor the period to Jun 27, 2026 | Document |
| Jul 28, 2026 | 144/A | Filing (amendment) | Document |
| Jul 23, 2026 | 8-K | Results of operations | Document |
| Jun 23, 2026 | 11-K | Employee stock plan reportfor the period to Dec 31, 2025 | Document |
| May 28, 2026 | SD | Conflict minerals report | Document |
| May 26, 2026 | 8-K | Shareholder vote | Document |
| May 11, 2026 | DEFA14A | Additional annual meeting material | Document |
| May 1, 2026 | 10-Q | Quarterly reportfor the period to Mar 28, 2026 | Document |
| Apr 30, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 23, 2026 | 8-K | Results of operations | Document |
| Apr 7, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Apr 7, 2026 | DEFA14A | Additional annual meeting material | Document |
| Apr 7, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 24, 2026 | 8-K | Other material events | Document |
| Feb 26, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
| Feb 12, 2026 | 8-K | Material agreement entered, other material events | Document |
| Jan 29, 2026 | 8-K | Results of operations | Document |
| Jan 23, 2026 | 25-NSE | One of its securities removed from an exchange (usually a matured note) | Document |
| Jan 21, 2026 | 25-NSE | One of its securities removed from an exchange (usually a matured note) | Document |
| Jan 12, 2026 | 8-K | Officer or director change | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since Feb 14, 1994: every report, 8-K, meeting and letter. Of its other filings (1,362 in all), the newest. Of its note and share prospectuses (424B, FWP), the newest 40 of 147.
The full analysis
What do Thermo Fisher Scientific's filings show?
The filings are where every one of Thermo Fisher Scientific's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.